Gozellix Kit
Product Images NDC 84552-500

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gozellix (NDC 84552-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Telix Innovations Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Gozellix 01)

Diagram illustrating the preparation process of Gozellix (Gozetotide) Kit, showing sequential steps mixing Gozetotide vial, acetate buffer, ascorbic acid stabilizer, Gallium Ga 68 chloride solution, and 0.9% sodium chloride injection, leading to quality control of the final Gallium Ga 68 Gozetotide Injection.*

FDA Label Image

Figure 2 (Gozellix 02)

A flowchart diagram titled 'GOZELLIX - Configuration A' illustrating the preparation steps for Gozetotide injection. It shows combining components such as Gozetotide (Vial 1), Acetate Buffer (Vial 2A), Ascorbic Acid Stabilizer (Ampule), Gallium Ga 68 Chloride Solution, ARTMS QIS Solid Target System, and 0.9% Sodium Chloride Injection, with specified volumes and instructions for mixing, leading to quality control assessment.*

FDA Label Image

Figure 3 (Gozellix 03)

Flowchart diagram titled 'GOZELLIX- Configuration A' illustrating the preparation process of Gozellix, showing steps from mixing Gozetotide vial with acetate buffer and ascorbic acid stabilizer to obtaining Gallium Ga 68 Gozetotide Injection, including use of EZAG Gallia Pharm Generator and quality control procedures.*

FDA Label Image

Figure 4 (Gozellix 04)

Diagram illustrating the preparation process of Gozellix (Gozetotide) Injection, starting from Gozetotide vial and acetate buffer mixed with ascorbic acid stabilizer. It shows stepwise combination with Gallium Ga 68 Chloride Solution and final addition of sodium chloride injection, concluding with quality control testing for radiochemical purity, pH, and appearance.*

FDA Label Image

Figure 5 (Gozellix 05)

Instructional diagram illustrating a rectangular test strip with marked sections including a top portion (approximately 5 cm), bottom portion (approximately 3 cm), and sample spot. Dimensions and cutting lines are indicated with scissors icons and measurements labeled in centimeters. The diagram shows the placement for separating portions of the strip for testing purposes.*

FDA Label Image

Chemical Structure (Gozellix 06)

Chemical structure diagram of Gozetotide showing molecular bonds and atoms, including gallium (Ga) coordination. The structure depicts the arrangement of functional groups and complexed atoms relevant to the active ingredient.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Gozellix kit for the preparation of gallium Ga 68 gozetotide injection, 25 mcg per vial. The label indicates this is a multiple-dose kit containing a Gozetotide vial, an Acetate Buffer vial, and an Ascorbic Acid stabilizer ampule. It is labeled for intravenous use only and manufactured by Telix Innovations SA.*

FDA Label Image

Principal Display Panel (Kit Carton)

Gozellix 25 mcg/vial gozetotide kit for the preparation of gallium Ga 68 gozetotide injection. The multiple-dose kit includes a vial of gozetotide, an acetate buffer vial, and an ascorbic acid stabilizer ampule. The label indicates it is for intravenous use only and is labeled by Telix Innovations SA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.